Поисковый запрос: (<.>A=Khazaeli, M. B.$<.>) |
Общее количество найденных документов : 27
Показаны документы с 1 по 20
|
|
1.
| Zhou Y.G. {9}{0}Y-Labeled 17-1А Monoclonal Antibody Prepared Using The New Bifunctional Chelating Agent DOTA-NHS // J. Labell. Compounds and Radiopharm., 1994. Vol. 35.-С.318-319
|
2.
| Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin // Cancer Res., 1995. Vol. 55, N 14.-С.3060-3067
|
3.
| Approaches to enhance cancer radioterapy employing gene transfer methods // Gene Ther., 1996. Vol. 3, N 12.-С.1042-1068
|
4.
| Approaches to enhance cancer radioterapy employing gene transfer methods // Gene Ther., 1996. Vol. 3, N 12.-С.1042-1068
|
5.
| Approaches to enhance cancer radioterapy employing gene transfer methods // Gene Ther., 1996. Vol. 3, N 12.-С.1042-1068
|
6.
| Production of a single chain anti-CEA antibody from the hybridoma cell line T84.66 using a modified colony-lift selection procedure to detect antigen-positive ScFv bacterial clones // Hybridoma, 1998. Vol. 17, N 1.-С.1-8
|
7.
| Idiotypic vaccination with a murine anti-dsDNA antibody. Phase I study in patients with nonactive systemic lupus erythematosus with nephritis // J. Rheumatol., 1999. Vol. 26, N 12.-С.2602-2608
|
8.
| Idiotypic vaccination with a murine anti-dsDNA antibody. Phase I study in patients with nonactive systemic lupus erythematosus with nephritis // J. Rheumatol., 1999. Vol. 26, N 12.-С.2602-2608
|
9.
| Idiotypic vaccination with a murine anti-dsDNA antibody. Phase I study in patients with nonactive systemic lupus erythematosus with nephritis // J. Rheumatol., 1999. Vol. 26, N 12.-С.2602-2608
|
10.
| Impact of patient-specific mass on liver dosimetry for radioimmunotherapy // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.86P
|
11.
| Impact of patient-specific mass on liver dosimetry for radioimmunotherapy // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.86P
|
12.
| Initial clinical experience with CC49 pretarget radioimmunotherapy using a new genetically engineered fusion protein // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.314
|
13.
| Initial clinical experience with CC49 pretarget radioimmunotherapy using a new genetically engineered fusion protein // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.314
|
14.
| Phase Phase I trial of multiple large doses of murine monoclonal antibody CO17-1А I: Clinical aspects // J. Nat. Cancer Inst., 1988. Vol. 80, N 12.-С.932-936
|
15.
| Phase I trial of multiple large doses of murine monoclonal antibody CO17-1А II: Pharmacokinetics and immune response // J. Nat. Cancer Inst., 1988. Vol. 80, N 12.-С.937-942
|
16.
| Shaw Denise R. Mouse/human chimeric antibodies to a tumor-associated antigen: Biologic activity of the four human IgG subclasses // J. Nat. Cancer Inst., 1988. Vol. 80, N 19.-С.1553-1559
|
17.
| Khazaeli M.B. Quantitative assay of a human monoclonal IgM antibody (НА-1А) in human serum // J. Immunol. Meth., 1989. Vol. 117, N 2.-С.175-180
|
18.
| Khazaeli M.B. Quantitative assay of a human monoclonal IgM antibody (HA-1А) in human serum // J. Immunol. Meth., 1989. Vol. 117, N 2.-С.175-180
|
19.
| Khazaeli M.B. Quantitation of mouse monoclonal antibody and human anti-mouse antibody response in serum of patients // Hybridoma, 1989. Vol. 8, N 2.-С.231-239
|
20.
| Khazaeli M.B. Quantitative assay of a human monoclonal IgM antibody (НА-1А) in human serum // J. Immunol. Meth., 1989. Vol. 117, N 2.-С.175-180
|
&uf('+1W2226#',v2226), ?>
|
|